Article
Integrating mutation and gene expression cross-sectional data to infer cancer progression.
BMC systems biology - 25 Jan 2016
Fleck Julia L, Pavel Ana B, Cassandras Christos G
Abstract excerpt
BACKGROUND: A major problem in identifying the best therapeutic targets for cancer is the molecular heterogeneity of the disease. Cancer is often caused by an accumulation of mutations which produce irreversible damage to the cell's control mechanisms of survival and proliferation. Different mutations may affect these cellular anachronisms through a combination of molecular interactions which may be dynamically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
